| scholarly article | Q13442814 |
| P50 | author | Young Joon Kwon | Q85291180 |
| Marni Falk | Q57158385 | ||
| P2093 | author name string | Michael Bennett | |
| Zhe Zhang | |||
| Rui Xiao | |||
| Erzsebet Polyak | |||
| Min Peng | |||
| Christoph Seiler | |||
| Shana E McCormack | |||
| Mai Tsukikawa | |||
| Julian Ostrovsky | |||
| Stephen D Dingley | |||
| P2860 | cites work | Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy | Q24321305 |
| N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities | Q24568289 | ||
| Supplementation with α-lipoic acid, CoQ10, and vitamin E augments running performance and mitochondrial function in female mice | Q27329547 | ||
| Fiji: an open-source platform for biological-image analysis | Q27860912 | ||
| Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders | Q28271871 | ||
| Primary respiratory chain disease causes tissue-specific dysregulation of the global transcriptome and nutrient-sensing signaling network | Q28534824 | ||
| Indirect inhibition of mitochondrial dihydroorotate dehydrogenase activity by nitric oxide | Q28619678 | ||
| Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides | Q73729841 | ||
| Mitochondrial diseases | Q95554206 | ||
| Vitamin E: Emerging aspects and new directions | Q38999837 | ||
| Pharmacologic targeting of sirtuin and PPAR signaling improves longevity and mitochondrial physiology in respiratory chain complex I mutant Caenorhabditis elegans. | Q39032373 | ||
| Flunarizine rescues reduced lifespan in CLN3 triple knock-out Caenorhabditis elegans model of batten disease | Q39264217 | ||
| Mitochondrial disease patients' perception of dietary supplements' use. | Q39573813 | ||
| The Effects of Ascorbate, N-Acetylcysteine, and Resveratrol on Fibroblasts from Patients with Mitochondrial Disorders | Q42323474 | ||
| The effect of different ubiquinones on lifespan in Caenorhabditis elegans | Q43124303 | ||
| Mitochondrial expression and function of GAS-1 in Caenorhabditis elegans | Q43559952 | ||
| An in vivo and in vitro study on the protective effects of N-acetylcysteine on mitochondrial dysfunction in isoproterenol treated myocardial infarcted rats | Q46154154 | ||
| The effects of complex I function and oxidative damage on lifespan and anesthetic sensitivity in Caenorhabditis elegans | Q47393888 | ||
| High-throughput BioSorter quantification of relative mitochondrial content and membrane potential in living Caenorhabditis elegans. | Q47751206 | ||
| Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems. | Q47988632 | ||
| N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins | Q48301059 | ||
| Vitamin E reduces endosulfan-induced toxic effects on morphology and behavior in early development of zebrafish (Danio rerio). | Q50463395 | ||
| Production of superoxide/H2O2 by dihydroorotate dehydrogenase in rat skeletal muscle mitochondria. | Q51729024 | ||
| Free radicals, metals and antioxidants in oxidative stress-induced cancer | Q29547711 | ||
| Mitochondrial respiratory chain dysfunction variably increases oxidant stress in Caenorhabditis elegans. | Q30539297 | ||
| The in-depth evaluation of suspected mitochondrial disease | Q33608204 | ||
| Integrated transcriptome analysis across mitochondrial disease etiologies and tissues improves understanding of common cellular adaptations to respiratory chain dysfunction | Q33617779 | ||
| N-acetylcysteine attenuates hexavalent chromium-induced hypersensitivity through inhibition of cell death, ROS-related signaling and cytokine expression | Q34233104 | ||
| The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis | Q34601400 | ||
| The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease | Q34626122 | ||
| Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials. | Q34685307 | ||
| A modern approach to the treatment of mitochondrial disease | Q35011397 | ||
| Vitamin E therapy in Parkinson's disease | Q35160394 | ||
| N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway. | Q35284048 | ||
| Stable isotopic profiling of intermediary metabolic flux in developing and adult stage Caenorhabditis elegans | Q35396081 | ||
| Inhibiting cytosolic translation and autophagy improves health in mitochondrial disease. | Q35924054 | ||
| Targeting antioxidants to mitochondria: a new therapeutic direction | Q36341069 | ||
| Cellular redox regulation and prooxidant signaling systems: a new perspective on the free radical theory of aging. | Q36520945 | ||
| Fluorescence-activated cell sorting analysis of mitochondrial content, membrane potential, and matrix oxidant burden in human lymphoblastoid cell lines. | Q36662103 | ||
| Metabolic pathway profiling of mitochondrial respiratory chain mutants in C. elegans. | Q36713732 | ||
| Vitamin E and neurodegenerative diseases | Q36738274 | ||
| Modulation of signal transduction by vitamin E. | Q36744240 | ||
| Molecular profiling of mitochondrial dysfunction in Caenorhabditis elegans | Q36763341 | ||
| How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria-targeted drugs. | Q36965904 | ||
| Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia | Q37129457 | ||
| Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society | Q37210464 | ||
| In vivo metabolic flux profiling with stable isotopes discriminates sites and quantifies effects of mitochondrial dysfunction in C. elegans. | Q37626877 | ||
| Animal and human studies with the mitochondria-targeted antioxidant MitoQ. | Q37774684 | ||
| Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits | Q38147790 | ||
| A review on the possible molecular mechanism of action of N-acetylcysteine against insulin resistance and type-2 diabetes development | Q38446927 | ||
| Oxidative stress in inherited mitochondrial diseases | Q38527423 | ||
| Mitochondria-targeted antioxidants | Q38562626 | ||
| Leigh syndrome: One disorder, more than 75 monogenic causes | Q38617364 | ||
| Pharmacologic modeling of primary mitochondrial respiratory chain dysfunction in zebrafish | Q38653585 | ||
| Attenuation of rotenone toxicity in SY5Y cells by taurine and N-acetyl cysteine alone or in combination | Q38853659 | ||
| Cellular and Molecular Mechanisms of Action of Mitochondria-Targeted Antioxidants | Q38962013 | ||
| Nutritional interventions in primary mitochondrial disorders: Developing an evidence base. | Q38963725 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P921 | main subject | acetylcysteine | Q375613 |
| P304 | page(s) | 449-462 | |
| P577 | publication date | 2018-02-23 | |
| P1433 | published in | Molecular Genetics and Metabolism | Q6895949 |
| P1476 | title | N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease. | |
| P478 | volume | 123 |
| Q64100690 | Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence |
| Q58709318 | Effects of N-acetyl-L-cysteine on lifespan, locomotor activity and stress-resistance of 3 species with different lifespans |
| Q92309425 | Fine Particulate Matter Leads to Unfolded Protein Response and Shortened Lifespan by Inducing Oxidative Stress in C. elegans |
| Q64943955 | Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies. |
| Q89064098 | N-acetylcysteine prevents ketamine-induced adverse effects on development, heart rate and monoaminergic neurons in zebrafish |
| Q57293416 | Towards a therapy for mitochondrial disease: an update |
| Q58722987 | Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study |
Search more.